James F. Cummings - 02 Feb 2026 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role: Chief Medical Officer
Signature: /s/ Edward Berg, Attorney-in-Fact
Issuer symbol: VXRT
Transactions as of: 02 Feb 2026
Net transactions value: -$4,847
Form type: 4
Filing time: 05 Feb 2026, 18:54:11 UTC
Previous filing: 01 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cummings James F.	Chief Medical Officer	C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO	/s/ Edward Berg, Attorney-in-Fact	05 Feb 2026	0001886760

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VXRT	Common Stock	Tax liability	$4,847	-7,965	-1.1%	$0.6085	737,792	02 Feb 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2026.
F2	This amount includes 75,618 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.